Metronidazole interaction with warfarin — ORE Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Potentiation of warfarin anticoagulation by metronidazole
Metronidazole potentiates warfarin anticoagulation by inhibiting its hepatic metabolism. UK prescribing guidance (eMC Marevan SmPC) explicitly identifies metronidazole as a drug that potentiates warfarin effect. The stereoselective interaction occurs because metronidazole, like disulfiram, inhibits CYP2C9 and reduces clearance of the active S-enantiomer of warfarin. The clinical presentation—rapid INR rise to 5.8 with gingival bleeding after 3 days of metronidazole—is consistent with potentiation, not reduced absorption. Distractor A reverses the mechanism. Distractors C (adrenaline toxicity) and D (chlorhexidine allergy) would not cause selective INR elevation. Distractor E (analgesic tolerance) is unrelated to anticoagulation.
Reference: UK eMC: Marevan 0.5 mg Tablets – Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/2803/smpc; Hassall CH, Gander RM. The stereoselective interaction of warfarin and metronidazole in man. J Clin Pharmacol. 1976;16(8–9):434–440.